Glucose Health, Inc. Appoints Veteran Financial Executive Edmund “Ned” Burke to Its Board of Directors

Rhea-AI Summary

Glucose Health (OTC: GLUC) appointed veteran financial executive Edmund “Ned” Burke to its Board of Directors effective October 23, 2025. Burke brings 40+ years of financial services leadership from firms including Pioneer Funds and Fidelity, and most recently served as CEO of ALPS Distributors.

Key track record items: Burke grew ALPS AUM from $15 million to $225 million (~19.79% CAGR over ~15 years), negotiated ALPS’ sale to Lovell Minnick in 2005, and oversaw its later acquisition by DST Systems in 2011. He also serves on boards of Financial Investors Trust, Clough Funds, and Liberty All-Star Trust. Management notes Burke is one of Glucose Health’s largest shareholders and will support the company’s growth strategy.

Positive

• ALPS AUM growth from $15M to $225M
• 19.79% CAGR at ALPS over ~15 years
• Burke is a company large shareholder aligning interests

Negative

• None.

News Market Reaction – GLUC

+75.00%

1 alert

+75.00% News Effect

On the day this news was published, GLUC gained 75.00%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

BENTONVILLE, Ark., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) is pleased to announce the appointment of Edmund (Ned) Burke, a highly accomplished financial services executive, to its Board of Directors. With more than four decades of leadership experience at prominent investment firms including Pioneer Funds and Fidelity Investments, Mr. Burke brings exceptional financial acumen and strategic insight to the company’s leadership team.

Mr. Burke most recently served as Chief Executive Officer of ALPS Distributors, Inc., where he played a pivotal role in the successful distribution of closed-end funds and exchange-traded funds (ETFs). Under his direction, ALPS expanded its services to include critical back-office accounting and transfer services for many of the nation’s top money management firms. During his tenure, Mr. Burke established and managed key relationships with notable organizations such as Select Sector SPDR Exchange Traded Funds, GE Investment Management, and Clough closed-end funds.

His outstanding contributions to the financial services industry were recognized in 2016 when he received the NOVA Award from the National Investment Company Service Association, honoring his leadership and innovation in the securities sector.

As CEO, Mr. Burke oversaw impressive growth at ALPS, expanding the firm’s Assets Under Management (AUM) from $15 million to $225 million, representing a compound annual growth rate of 19.79% over approximately 15 years. In 2005, he successfully negotiated the sale of ALPS to Lovell Minnick Partners, a private equity firm specializing in financial services investments. Later, in 2011, DST Systems, Inc. acquired ALPS after Mr. Burke had firmly established it as a leading player in the financial services industry.

Mr. Burke’s extensive experience in building and scaling financial organizations will be invaluable as Glucose Health, Inc., continues to expand operations and enhance shareholder value. In addition to his new role at Glucose Health, Mr. Burke serves on the boards of several prominent money management firms, including Financial Investors Trust, Clough Funds, and Liberty All-Star Trust.

Commenting on the appointment, Mark Schaftlein, CEO of Glucose Health, stated:

“Ned is an outstanding addition to our Board of Directors. His deep industry expertise and proven success in building high-performing organizations will be instrumental as we continue to advance Glucose Health’s growth strategy. As one of our largest shareholders, Ned’s interests are perfectly aligned with those of our broader shareholder base, and I look forward to working closely with him to achieve our long-term objectives.”

Mr. Burke earned a Bachelor of Arts degree in Economics from the University of New Hampshire.

Contact:
Investor Relations
info@glucosehealthinc.com
www.glucodown.com
www.fiberup.com
OTC: GLUC

FAQ

Who is Edmund “Ned” Burke and why did Glucose Health (GLUC) add him to the board on October 23, 2025?

Burke is a 40+ year financial services executive and former CEO of ALPS Distributors; he was added for his industry experience and strategic financial expertise.

How did Ned Burke grow ALPS AUM before joining Glucose Health’s board?

He expanded ALPS AUM from $15 million to $225 million, a reported 19.79% CAGR over about 15 years.

Does Ned Burke hold shares in Glucose Health (GLUC) and what does that mean for investors?

Yes; the company said Burke is one of its largest shareholders, indicating his interests are aligned with other shareholders.

What previous exits or transactions has Ned Burke led that are relevant to GLUC investors?

He negotiated ALPS’ sale to Lovell Minnick in 2005 and ALPS was later acquired by DST Systems in 2011.

Will Ned Burke’s appointment to Glucose Health’s board change company strategy or guidance immediately?

The announcement states Burke will support the growth strategy but does not disclose any immediate changes to strategy or financial guidance.

How can investors contact Glucose Health investor relations about the board appointment (GLUC)?

Investors can contact Investor Relations at info@glucosehealthinc.com or visit www.glucodown.com and www.fiberup.com.